Profile
Full Name
Skye Bioscience, Inc.Ticker Symbol
SKYEExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
November 26, 2014Indexes
Not includedWebsite
http://skyebioscience.comEmployees
16Key Details
Price
$1.63(-4.56%)
Market cap
$50.55M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.73(+86.41% YoY)
PE ratio
-
Next earnings date
May 8, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Skye Bioscience doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 21, 25 Craig-Hallum
BuyMar 21, 25 Citizens Capital Markets
Market OutperformFeb 28, 25 William Blair
OutperformSep 30, 24 Scotiabank
Sector OutperformSep 20, 24 Piper Sandler
OverweightSep 20, 24 Cantor Fitzgerald
OverweightSep 10, 24 JMP Securities
Market OutperformSep 9, 24 Cantor Fitzgerald
OverweightSep 6, 24 Cantor Fitzgerald
OverweightAug 27, 24 Cantor Fitzgerald
OverweightInstitutional Ownership
- What is the ticker symbol for Skye Bioscience?
- Does Skye Bioscience pay dividends?
- What sector is Skye Bioscience in?
- What industry is Skye Bioscience in?
- What country is Skye Bioscience based in?
- When did Skye Bioscience go public?
- Is Skye Bioscience in the S&P 500?
- Is Skye Bioscience in the NASDAQ 100?
- Is Skye Bioscience in the Dow Jones?
- When was Skye Bioscience's last earnings report?
- When does Skye Bioscience report earnings?
- Should I buy Skye Bioscience stock now?
What is the ticker symbol for Skye Bioscience?
The ticker symbol for Skye Bioscience is NASDAQ:SKYE
Does Skye Bioscience pay dividends?
No, Skye Bioscience does not pay dividends
What sector is Skye Bioscience in?
Skye Bioscience is in the Healthcare sector
What industry is Skye Bioscience in?
Skye Bioscience is in the Biotechnology industry
What country is Skye Bioscience based in?
Skye Bioscience is headquartered in United States
When did Skye Bioscience go public?
Skye Bioscience's initial public offering (IPO) was on November 26, 2014
Is Skye Bioscience in the S&P 500?
No, Skye Bioscience is not included in the S&P 500 index
Is Skye Bioscience in the NASDAQ 100?
No, Skye Bioscience is not included in the NASDAQ 100 index
Is Skye Bioscience in the Dow Jones?
No, Skye Bioscience is not included in the Dow Jones index
When was Skye Bioscience's last earnings report?
Skye Bioscience's most recent earnings report was on Mar 20, 2025
When does Skye Bioscience report earnings?
The next expected earnings date for Skye Bioscience is May 8, 2025
Should I buy Skye Bioscience stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions